Trial intelligence / Profile preview

Doxycycline versus placebo for symptomatic knee osteoarthritis

NL-OMON26143Recruiting

Sponsor
Sint Maartenskliniek
Start
Dec 2007
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in knee osteoarthritis (OA) and osteoarthritis (OA) comparing Doxycycline with Placebo (2 arms). Primary endpoint: OMERACT-OARSI clinical responder rate at week 24. Started Dec 2007; status: recruiting.

02

Drugs

doxycycline
03

Conditions

knee osteoarthritis (OA)osteoarthritis (OA)

Beyond the preview

Go deeper on NL-OMON26143.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON26143.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call